148 related articles for article (PubMed ID: 38565774)
1. Suppression of JAK2/STAT3 Pathway by Notoginsenoside R1 Reduces Epithelial-Mesenchymal Transition in Non-small Cell Lung Cancer.
Wan M; Yu H; Zhai H
Mol Biotechnol; 2024 Apr; ():. PubMed ID: 38565774
[TBL] [Abstract][Full Text] [Related]
2. Notoginsenoside R1 counteracts mesenchymal stem cell-evoked oncogenesis and doxorubicin resistance in osteosarcoma cells by blocking IL-6 secretion-induced JAK2/STAT3 signaling.
Lu M; Xie K; Lu X; Lu L; Shi Y; Tang Y
Invest New Drugs; 2021 Apr; 39(2):416-425. PubMed ID: 33128383
[TBL] [Abstract][Full Text] [Related]
3. Notoginsenoside R1 relieves the myocardial infarction via activating the JAK2/STAT3 signaling pathway in vivo and in vitro.
Xu H; Zhang X; Shi Y; Yu K; Jiang Y
Bioengineered; 2022 Mar; 13(3):5653-5662. PubMed ID: 35263202
[TBL] [Abstract][Full Text] [Related]
4. Procyanidins mediates antineoplastic effects against non-small cell lung cancer via the JAK2/STAT3 pathway.
Wu Y; Liu C; Niu Y; Xia J; Fan L; Wu Y; Gao W
Transl Cancer Res; 2021 May; 10(5):2023-2035. PubMed ID: 35116524
[TBL] [Abstract][Full Text] [Related]
5. JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells.
Liu RY; Zeng Y; Lei Z; Wang L; Yang H; Liu Z; Zhao J; Zhang HT
Int J Oncol; 2014 May; 44(5):1643-51. PubMed ID: 24573038
[TBL] [Abstract][Full Text] [Related]
6. STAT3 aggravates TGF-β1-induced hepatic epithelial-to-mesenchymal transition and migration.
Wang B; Liu T; Wu JC; Luo SZ; Chen R; Lu LG; Xu MY
Biomed Pharmacother; 2018 Feb; 98():214-221. PubMed ID: 29268242
[TBL] [Abstract][Full Text] [Related]
7. α-Hederin inhibits interleukin 6-induced epithelial-to-mesenchymal transition associated with disruption of JAK2/STAT3 signaling in colon cancer cells.
Sun D; Shen W; Zhang F; Fan H; Xu C; Li L; Tan J; Miao Y; Zhang H; Yang Y; Cheng H
Biomed Pharmacother; 2018 May; 101():107-114. PubMed ID: 29477470
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
9. Long Noncoding RNA HOST2 Promotes Epithelial-Mesenchymal Transition, Proliferation, Invasion and Migration of Hepatocellular Carcinoma Cells by Activating the JAK2-STAT3 Signaling Pathway.
Wu Y; Yuan T; Wang WW; Ge PL; Gao ZQ; Zhang G; Tang Z; Dang XW; Zhao YF; Zhang JY; Jiang GZ
Cell Physiol Biochem; 2018; 51(1):301-314. PubMed ID: 30453302
[TBL] [Abstract][Full Text] [Related]
10. Oridonin represses epithelial-mesenchymal transition and angiogenesis of thyroid cancer via downregulating JAK2/STAT3 signaling.
Liu W; Wang X; Wang L; Mei Y; Yun Y; Yao X; Chen Q; Zhou J; Kou B
Int J Med Sci; 2022; 19(6):965-974. PubMed ID: 35813296
[TBL] [Abstract][Full Text] [Related]
11. Activation of histamine H4 receptors decreases epithelial-to-mesenchymal transition progress by inhibiting transforming growth factor-β1 signalling pathway in non-small cell lung cancer.
Cai WK; Hu J; Li T; Meng JR; Ma X; Yin SJ; Zhao CH; He GH; Xu GL
Eur J Cancer; 2014 Apr; 50(6):1195-206. PubMed ID: 24447834
[TBL] [Abstract][Full Text] [Related]
12. Ginsenoside Rh4 Suppressed Metastasis of Lung Adenocarcinoma via Inhibiting JAK2/STAT3 Signaling.
Zhang Y; Ma P; Duan Z; Liu Y; Mi Y; Fan D
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216134
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of Human Papillomavirus Type 16 Oncoproteins Enhances Epithelial-Mesenchymal Transition via STAT3 Signaling Pathway in Non-Small Cell Lung Cancer Cells.
Zhang W; Wu X; Hu L; Ma Y; Xiu Z; Huang B; Feng Y; Tang X
Oncol Res; 2017 May; 25(5):843-852. PubMed ID: 28508744
[TBL] [Abstract][Full Text] [Related]
14. IL-27 inhibits epithelial-mesenchymal transition and angiogenic factor production in a STAT1-dominant pathway in human non-small cell lung cancer.
Kachroo P; Lee MH; Zhang L; Baratelli F; Lee G; Srivastava MK; Wang G; Walser TC; Krysan K; Sharma S; Dubinett SM; Lee JM
J Exp Clin Cancer Res; 2013 Nov; 32(1):97. PubMed ID: 24274066
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of TRIM66 inhibits cell proliferation, migration and invasion in colorectal cancer through JAK2/STAT3 pathway.
He T; Cui J; Wu Y; Sun X; Chen N
Life Sci; 2019 Oct; 235():116799. PubMed ID: 31472144
[TBL] [Abstract][Full Text] [Related]
16. MARVELD3 inhibits the epithelial-mesenchymal transition and cell migration by suppressing the Wnt/β-catenin signaling pathway in non-small cell lung cancer cells.
Li S; Qi S; Li Y; Zhang C; Sun L; Liu C; Wang H
Thorac Cancer; 2023 Apr; 14(12):1045-1058. PubMed ID: 36924014
[TBL] [Abstract][Full Text] [Related]
17. Notoginsenoside R1 promotes Lgr5
Yu ZL; Gao RY; Lv C; Geng XL; Ren YJ; Zhang J; Ren JY; Wang H; Ai FB; Wang ZY; Zhang BB; Liu DH; Yue B; Wang ZT; Dou W
Acta Pharmacol Sin; 2024 Mar; ():. PubMed ID: 38491161
[TBL] [Abstract][Full Text] [Related]
18. Silencing of ITGB6 inhibits the progression of cervical carcinoma via regulating JAK/STAT3 signaling pathway.
Zheng X; Zhu Y; Wang X; Hou Y; Fang Y
Ann Transl Med; 2021 May; 9(9):803. PubMed ID: 34268416
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-449b-3p inhibits epithelial-mesenchymal transition by targeting IL-6 and through the JAK2/STAT3 signaling pathway in non-small cell lung cancer.
Cai K; Li HX; Li PP; Guo ZJ; Yang Y
Exp Ther Med; 2020 Apr; 19(4):2527-2534. PubMed ID: 32256731
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-32α inactivates JAK2/STAT3 signaling and reverses interleukin-6-induced epithelial-mesenchymal transition, invasion, and metastasis in pancreatic cancer cells.
Chen J; Wang S; Su J; Chu G; You H; Chen Z; Sun H; Chen B; Zhou M
Onco Targets Ther; 2016; 9():4225-37. PubMed ID: 27471397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]